Jennipher Immanuel Manohar
Psychiatric/Mental Health · Columbia, SCNPI 1215713599
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 94.3% of the total across 276 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 10 manufacturers reported payments, led by Teva Pharmaceuticals USA, Inc. at 26.4% of the total.
Across 276 payments — averaging $13.31 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Teva Pharmaceuticals USA, Inc.$970
- Neurocrine Biosciences, Inc.$496
- Alkermes, Inc.$475
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$456
- E.r. Squibb & Sons, L.L.C.$435
- Otsuka America Pharmaceutical, Inc.$371
- plus $472 from 4 others
What the payments were for
- Food & beverage$3,46494%
- Education$2116%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 95 | $970 |
| Neurocrine Biosciences, Inc. | 40 | $496 |
| Alkermes, Inc. | 30 | $475 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 27 | $456 |
| E.r. Squibb & Sons, L.L.C. | 24 | $435 |
| Otsuka America Pharmaceutical, Inc. | 24 | $371 |
| Johnson & Johnson | 14 | $228 |
| AbbVie | 18 | $160 |
| Vanda Pharmaceuticals Inc. | 3 | $66 |
| Lundbeck LLC | 1 | $19 |
How this compares
$3,675 in reported general payments places this provider in the 85th percentile of 354 psychiatric/mental health providers in South Carolina.
See all psychiatric/mental health providers in South Carolina →
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Quetiapine Fumarate | 19 | $410 |
| Divalproex Sodium ErDivalproex Sodium | 15 | $281 |
| Olanzapine | 17 | $174 |
| Benztropine Mesylate | 15 | $170 |
| Trazodone Hcl | 12 | $69 |
| Mirtazapine | 11 | $55 |
Paid to pharmacies, not to this prescriber.
Other psychiatric/mental health in Columbia
- Elizabeth EggebrechtColumbia$11K
- Natalie VerenesColumbia$10K
- April HuttoColumbia$6K
- Penny LoyaColumbia$5K
- Milissa DavisColumbia$5K
- Cheryl SuberColumbia$4K
- Henretta MiltonColumbia$4K
- Regina HensleyColumbia$3K
- Steven KrozerGreenville$139K
- Luron FlemingGreenville$61K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.